c.i. 42510 has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, X; Fan, X; Han, J; Ning, L; Tang, S; Wang, C | 1 |
| Cervetto, C; Di Cesare Mannelli, L; Ghelardini, C; Marcoli, M; Maura, G; Micheli, L; Zanardelli, M | 1 |
2 other study(ies) available for c.i. 42510 and Neuralgia
| Article | Year |
|---|---|
Role of TRPV4-P2X7 Pathway in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion.
Topics: Animals; Ganglia, Spinal; Hyperalgesia; Leucine; Male; Morpholines; Nerve Compression Syndromes; Neuralgia; Purinergic P2X Receptor Antagonists; Pyrroles; Rats, Wistar; Receptors, Purinergic P2X7; Rosaniline Dyes; Signal Transduction; Sulfonamides; TRPV Cation Channels | 2021 |
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
Topics: Analgesics; Animals; Antineoplastic Agents; Benzenesulfonates; Carbenoxolone; Cell Death; Cell Line, Tumor; Cerebral Cortex; Colonic Neoplasms; Connexins; Glutamic Acid; Humans; Male; Nerve Tissue Proteins; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Purinergic P2X Receptor Antagonists; Pyridines; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Synaptosomes; Tetrazoles | 2015 |